Macrophage dynamics in prostate cancer: Molecular to therapeutic insights
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tumor-associated macrophages (TAMs) significantly impact prostate cancer (PCa) progression. Targeting M1 and M2 macrophage polarization offers a promising therapeutic strategy for PCa treatment.
Area Of Science
- Oncology
- Immunology
- Cell Biology
Background
- Prostate cancer (PCa) development and prognosis are heavily influenced by macrophages within the tumor microenvironment.
- Tumor-associated macrophages (TAMs) play a critical role in modulating the tumor microenvironment and influencing cancer progression.
Purpose Of The Study
- To examine the role of TAMs in prostate cancer (PCa) progression.
- To investigate factors influencing M1 and M2 macrophage polarization in PCa.
- To explore therapeutic strategies targeting macrophage polarization for PCa treatment.
Main Methods
- Review of existing literature on TAMs, macrophage polarization (M1/M2), and their role in PCa.
- Analysis of factors affecting macrophage polarization, including non-coding RNA and exosomes.
- Examination of therapeutic implications of targeting macrophage polarization in PCa.
Main Results
- M1 macrophages exhibit anti-tumor properties via pro-inflammatory cytokines (e.g., IFN-γ, TNF-α).
- M2 macrophages promote tumor cell migration and invasion via factors like Arg1 and IL-10.
- Macrophage polarization is a key determinant in PCa progression, influenced by non-coding RNA and exosomes.
Conclusions
- Targeting macrophage polarization presents a novel therapeutic approach for PCa.
- Further research into molecular mechanisms and combination therapies is crucial for effective treatment.
- TAMs represent a significant therapeutic target for improving PCa treatment efficacy.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...